This HTML5 document contains 36 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n12http://linked.opendata.cz/resource/drugbank/drug/DB07377/identifier/pdb/
n11http://bio2rdf.org/drugbank:
n7http://linked.opendata.cz/resource/drugbank/drug/DB07377/identifier/pubchem-compound/
n8http://linked.opendata.cz/resource/drugbank/drug/DB07377/identifier/pubchem-substance/
admshttp://www.w3.org/ns/adms#
n9http://linked.opendata.cz/resource/drugbank/drug/DB07377/identifier/drugbank/
n14http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
owlhttp://www.w3.org/2002/07/owl#
n3http://linked.opendata.cz/ontology/drugbank/
n4http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n13http://linked.opendata.cz/resource/drugbank/drug/DB07377/identifier/chemspider/

Statements

Subject Item
n2:DB07377
rdf:type
n3:Drug
n3:group
experimental
owl:sameAs
n11:DB07377 n14:DB07377
dcterms:title
N'-((2S,3R)-3-AMINO-2-HYDROXY-5-(ISOPROPYLSULFANYL)PENTANOYL)-N-3-CHLOROBENZOYL HYDRAZIDE
adms:identifier
n7:448285 n8:99443848 n9:DB07377 n12:AO5 n13:395131
n3:IUPAC-Name
n4:271B3E89-363D-11E5-9242-09173F13E4C5
n3:InChI
n4:271B3E8F-363D-11E5-9242-09173F13E4C5
n3:Molecular-Formula
n4:271B3E8E-363D-11E5-9242-09173F13E4C5
n3:Molecular-Weight
n4:271B3E8B-363D-11E5-9242-09173F13E4C5
n3:Monoisotopic-Weight
n4:271B3E8C-363D-11E5-9242-09173F13E4C5
n3:SMILES
n4:271B3E8D-363D-11E5-9242-09173F13E4C5
n3:Water-Solubility
n4:271B3E87-363D-11E5-9242-09173F13E4C5
n3:logP
n4:271B3E85-363D-11E5-9242-09173F13E4C5 n4:271B3E88-363D-11E5-9242-09173F13E4C5
n3:logS
n4:271B3E86-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Acceptor-Count
n4:271B3E95-363D-11E5-9242-09173F13E4C5
n3:H-Bond-Donor-Count
n4:271B3E96-363D-11E5-9242-09173F13E4C5
n3:InChIKey
n4:271B3E90-363D-11E5-9242-09173F13E4C5
n3:Polar-Surface-Area--PSA-
n4:271B3E91-363D-11E5-9242-09173F13E4C5
n3:Polarizability
n4:271B3E93-363D-11E5-9242-09173F13E4C5
n3:Refractivity
n4:271B3E92-363D-11E5-9242-09173F13E4C5
n3:Rotatable-Bond-Count
n4:271B3E94-363D-11E5-9242-09173F13E4C5
n3:Bioavailability
n4:271B3E9B-363D-11E5-9242-09173F13E4C5
n3:Ghose-Filter
n4:271B3E9D-363D-11E5-9242-09173F13E4C5
n3:MDDR-Like-Rule
n4:271B3E9E-363D-11E5-9242-09173F13E4C5
n3:Number-of-Rings
n4:271B3E9A-363D-11E5-9242-09173F13E4C5
n3:Physiological-Charge
n4:271B3E99-363D-11E5-9242-09173F13E4C5
n3:Rule-of-Five
n4:271B3E9C-363D-11E5-9242-09173F13E4C5
n3:Traditional-IUPAC-Name
n4:271B3E8A-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-acidic-
n4:271B3E97-363D-11E5-9242-09173F13E4C5
n3:pKa--strongest-basic-
n4:271B3E98-363D-11E5-9242-09173F13E4C5